US Patent Issued on March 17 for "Hexokinase 1 isoform B for use as a prognosis marker and specific target against cancer" (Turkish Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,578,339, issued on March 17.

"Hexokinase 1 isoform B for use as a prognosis marker and specific target against cancer" was invented by Yasemin Yozgat (Istanbul).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an isoform of hexokinase 1 (HK1), namely hexokinase 1b (HK1b), for use as a prognosis marker and as a specific target for use in treatment of cancer."

The patent was filed on July 19, 2020, under Application No. 17/597,743.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&...